Luteal Phase (LP)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 13, 2026

The Luteal Phase (LP) is the second half of the menstrual cycle, beginning at ovulation and ending at the onset of menstruation or, if conception occurs, continuing under the hormonal rescue of early pregnancy. It is defined clinically by the transformation of the ruptured follicle into the corpus luteum, which secretes progesterone and estradiol to prepare the endometrium for implantation. In a healthy cycle, the luteal phase typically spans 12 to 16 days.¹

Progesterone is the defining hormone of the luteal phase. It shifts the endometrium from proliferative to secretory, creates the biochemical environment necessary for embryo adhesion, and suppresses uterine contractility. A luteal phase that is too short or marked by inadequate progesterone output impairs all three of these functions. The result is either failure to conceive or early pregnancy loss before the couple knows a conception occurred.

In RRM practice, the luteal phase is evaluated using cycle-timed progesterone measurements drawn at specific points relative to Peak Day. A single random progesterone draw has limited diagnostic value; the parabolic shape of progesterone secretion across the phase means that timing relative to ovulation is everything. Multiple measurements in a single cycle, or serial evaluation across cycles, reveal patterns that a snapshot cannot.

Luteal phase evaluation is a core component of the root cause diagnosis in couples presenting with infertility or recurrent pregnancy loss. Shortened luteal phase, abnormal progesterone patterns, and deficient estradiol in the luteal phase are all treatable findings. Identifying them requires charting. Without it, clinicians are working from incomplete data.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.